Impact of Adding Rapid Polymerase Chain Reaction-based Blood Culture Identification Panel to Antimicrobial...

Area of Science:

• Clinical Microbiology
• Infectious Diseases
• Antimicrobial Stewardship

Background:

• Antimicrobial resistance necessitates rapid diagnostic tools.
• Traditional blood cultures have limitations in speed for timely intervention.
• Antimicrobial Stewardship Programs (ASPs) aim to optimize antibiotic use.

Purpose of the Study:

• To evaluate the impact of integrating a rapid Polymerase Chain Reaction (PCR)-based blood culture identification panel into an existing ASP.
• To assess the effect of rapid identification on antimicrobial prescribing patterns and clinical decision-making.

Main Methods:

• Prospective observational study design.
• Implementation of a multiplex PCR assay for direct identification of pathogens and resistance markers from positive blood cultures.
• Comparison of outcomes before and after the integration of the rapid PCR panel.

Main Results:

• Significant reduction in the time to pathogen identification and targeted antimicrobial therapy.
• Observed changes in antibiotic prescribing, including de-escalation and narrower spectrum agent use.
• Positive impact on key ASP metrics and potential for improved patient outcomes.

Conclusions:

• Rapid PCR-based blood culture identification panels are valuable additions to ASPs.
• Integration facilitates faster, more accurate antimicrobial treatment decisions.
• This technology supports antimicrobial stewardship goals and potentially reduces the burden of antimicrobial resistance.